Global Plastics in Personalized Drug Delivery Systems Market Size Study & Forecast, by Type, End Use, and Regional Forecasts 2025-2035

The Global Plastics in Personalized Drug Delivery Systems Market is estimated to be valued at approximately USD 1.99 billion in 2024 and is projected to expand at a noteworthy CAGR of 10.79% over the forecast period from 2025 to 2035. Personalized medicine continues to radically transform the pharmaceutical industry, and at the heart of this revolution lies a dynamic interplay of engineering-grade polymers that are redefining drug delivery paradigms. Plastics such as PLA, PLGA, PEG, PU, and PEEK are increasingly being engineered with biocompatibility, controlled release, and degradation kinetics tailored to individual therapeutic needs. These materials form the backbone of highly efficient drug-eluting devices, smart capsules, microneedle arrays, and implantable reservoirs—creating precision vehicles that enable drugs to reach their targets with unmatched specificity and timed bioavailability.

As precision medicine gathers momentum, the need to deliver biologics, gene therapies, and patient-specific regimens safely and efficiently is amplifying the demand for performance plastics. Biodegradable materials like PLGA (Poly(lactic-co-glycolic acid)) and PEG (Polyethylene glycol) have become frontrunners in the development of nanoscale and depot-based delivery platforms, owing to their tunable mechanical properties, enzymatic sensitivity, and regulatory approval track records. Meanwhile, PEEK (Polyether ether ketone), a robust thermoplastic, is gaining traction in implant-based systems, especially where sustained drug elution is necessary in complex therapeutic environments. Innovations in polymer science, particularly at the intersection of AI-guided formulation and 3D printing, are enabling bespoke manufacturing of delivery systems at an unprecedented scale and precision.

From a regional perspective, North America maintains a dominant foothold, driven by a high concentration of biotech innovators, favorable reimbursement policies, and robust clinical trials for novel therapeutics. The U.S., in particular, is witnessing large-scale adoption of polymer-based delivery systems in oncology, endocrinology, and neurology. Europe follows with strong momentum, attributed to a maturing regulatory landscape favoring biodegradable and patient-centric devices, particularly in countries like Germany, Switzerland, and the Netherlands. Asia Pacific is poised for the fastest growth, led by China, India, and Japan, where expanding healthcare infrastructure, growing pharma manufacturing ecosystems, and rising patient awareness around personalized therapies are collectively propelling demand for advanced plastic-based systems in drug delivery.

Major market player included in this report are:
• BASF SE
• Evonik Industries AG
• DuPont de Nemours Inc.
• Celanese Corporation
• SABIC
• Solvay S.A.
• Covestro AG
• Eastman Chemical Company
• Mitsubishi Chemical Group
• RTP Company
• Ensinger GmbH
• Victrex plc
• Arkema S.A.
• Lubrizol Corporation
• Röchling Group

Global Plastics in Personalized Drug Delivery Systems Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Type:
• PLA
• PLGA
• PEG
• PU
• PEEK

By End Use:
• Pharmaceuticals & Drug Delivery
• Medical Devices & Implants
• Healthcare & Clinics

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.